In support of the above argument, we have revealed that the frequency of peripheral Eomes+ Th cells (Eomes frequency) acted as a reliable biomarker for SPMS patients at risk of worsening disease (i.e., neurodegeneration) [24]. This evidence concerns the gene EOMES and secondary progressive multiple sclerosis.